As PDAC is a highly aggressive and metastatic cancer, we initially assessed the direct effects of pharmacological FAK inhibition on cell movement in 2.5-dimensional (2.5D) cell-derived matrices (CDMs) using primary cells lines generated from the KPC model of PC (27, 35, 36). The gene discussed is PTK2; the disease is metastatic malignant neoplasm.